Lack of specifics on obesity pill sales hover over Lilly’s first quarter
Lack of specifics on obesity pill sales hover over Lilly’s first quarter
Lack of specifics on obesity pill sales hover over Lilly’s first quarter
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.